Thursday, June 18, 2026
Home Authors Posts by Ogkologos

Ogkologos

4257 POSTS 0 COMMENTS

Datopotamab Deruxtecan Improves Survival Over Chemotherapy in Patients with Previously Untreated,...

Ogkologos -
0

Clinical Activity of Elraglusib with Gemcitabine Plus Nab-paclitaxel in First-Line Treatment...

Ogkologos -
0

EMA Recommends Granting a Conditional Marketing Authorisation for Nadofaragene Firadenovec

Ogkologos -
0

Pembrolizumab Plus Weekly Paclitaxel, With Or Without Bevacizumab, Improves OS in...

Ogkologos -
0

EMA Recommends Extension of Indications for Serplulimab

Ogkologos -
0

Adding Relacorilant to Nab-paclitaxel Prolongs OS in Patients with Platinum-Resistant Ovarian...

Ogkologos -
0

Quadruplet Isa-KRd Regimen Improves NGS-MRD Negativity in Transplant-Eligible Patients with Newly...

Ogkologos -
0

EMA Recommends Granting a Marketing Authorisation for Tarlatamab

Ogkologos -
0

Transdermal Oestradiol Patches Non-inferior to LHRH Agonists Regarding Metastasis-Free Survival in...

Ogkologos -
0

EMA Recommends Extension of Indications for Selpercatinib

Ogkologos -
0
1...567...426Page 6 of 426

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com